Back to newsJPMorgan cuts Rhythm Pharmaceuticals target price to $145 from $146RRYTM•2026-10-15JPMorgan cut its target price for Rhythm Pharmaceuticals to $145 from $146.Related NewsAargenx sets third-quarter 2026 financial results callARGX•2026-10-15EGrafTech International raises target price to $8 from $7EAF•2026-10-15TTetra Tech: RBC cuts target price to $44 from $46TTEK•2026-10-15FFMC Corp: RBC cuts target price to $9 from $11FMC•2026-10-15OStoneX initiates coverage of onsemi with buy rating and $110 target priceON•2026-10-15
RYTM•RYTM•RYTM•RYTM•
